Effects of various doses of aspirin on platelet activity and endothelial function

Takashi Furuno, Fumiyasu Yamasaki, Takeshi Yokoyama, Kyoko Sato, Takayuki Sato, Yoshinori Doi, Tetsuro Sugiura

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Although aspirin has become an established medicine for cardiac and cerebrovascular diseases, the optimal dose remains unknown. We evaluated the optimal dose of aspirin on platelet activity and endothelial function by administering 11 healthy male volunteers (32 ± 6 years of age) doses of aspirin that were increased in a stepwise manner (0, 81, 162, 330 and 660 mg/day) every 3 days. Platelet activity was assessed as surface P-selectin expression (%) measured by flow cytometry and the platelet aggregation ratio. Endothelial function in the brachial artery was assessed by measuring flow-mediated dilation (FMD) before and after reactive hyperemia. Platelet aggregation and P-selectin expression were significantly and dose-dependently suppressed (81-660 mg), and the FMD ratio tended to increase from 0 to 162 mg, but decreased significantly at 660 mg. In conclusion, although aspirin suppressed platelet activity and even surface P-selectin expression, higher doses worsened endothelial-mediated arterial dilation.

Original languageEnglish
Pages (from-to)267-273
Number of pages7
JournalHeart and Vessels
Volume26
Issue number3
DOIs
Publication statusPublished - May 1 2011
Externally publishedYes

Fingerprint

Aspirin
P-Selectin
Blood Platelets
Dilatation
Platelet Aggregation
Cerebrovascular Disorders
Brachial Artery
Hyperemia
Heart Diseases
Healthy Volunteers
Flow Cytometry

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

Effects of various doses of aspirin on platelet activity and endothelial function. / Furuno, Takashi; Yamasaki, Fumiyasu; Yokoyama, Takeshi; Sato, Kyoko; Sato, Takayuki; Doi, Yoshinori; Sugiura, Tetsuro.

In: Heart and Vessels, Vol. 26, No. 3, 01.05.2011, p. 267-273.

Research output: Contribution to journalArticle

Furuno, T, Yamasaki, F, Yokoyama, T, Sato, K, Sato, T, Doi, Y & Sugiura, T 2011, 'Effects of various doses of aspirin on platelet activity and endothelial function', Heart and Vessels, vol. 26, no. 3, pp. 267-273. https://doi.org/10.1007/s00380-010-0054-8
Furuno, Takashi ; Yamasaki, Fumiyasu ; Yokoyama, Takeshi ; Sato, Kyoko ; Sato, Takayuki ; Doi, Yoshinori ; Sugiura, Tetsuro. / Effects of various doses of aspirin on platelet activity and endothelial function. In: Heart and Vessels. 2011 ; Vol. 26, No. 3. pp. 267-273.
@article{8c2db79311d7431a91ef257cfecf412a,
title = "Effects of various doses of aspirin on platelet activity and endothelial function",
abstract = "Although aspirin has become an established medicine for cardiac and cerebrovascular diseases, the optimal dose remains unknown. We evaluated the optimal dose of aspirin on platelet activity and endothelial function by administering 11 healthy male volunteers (32 ± 6 years of age) doses of aspirin that were increased in a stepwise manner (0, 81, 162, 330 and 660 mg/day) every 3 days. Platelet activity was assessed as surface P-selectin expression ({\%}) measured by flow cytometry and the platelet aggregation ratio. Endothelial function in the brachial artery was assessed by measuring flow-mediated dilation (FMD) before and after reactive hyperemia. Platelet aggregation and P-selectin expression were significantly and dose-dependently suppressed (81-660 mg), and the FMD ratio tended to increase from 0 to 162 mg, but decreased significantly at 660 mg. In conclusion, although aspirin suppressed platelet activity and even surface P-selectin expression, higher doses worsened endothelial-mediated arterial dilation.",
author = "Takashi Furuno and Fumiyasu Yamasaki and Takeshi Yokoyama and Kyoko Sato and Takayuki Sato and Yoshinori Doi and Tetsuro Sugiura",
year = "2011",
month = "5",
day = "1",
doi = "10.1007/s00380-010-0054-8",
language = "English",
volume = "26",
pages = "267--273",
journal = "Heart and Vessels",
issn = "0910-8327",
publisher = "Springer Japan",
number = "3",

}

TY - JOUR

T1 - Effects of various doses of aspirin on platelet activity and endothelial function

AU - Furuno, Takashi

AU - Yamasaki, Fumiyasu

AU - Yokoyama, Takeshi

AU - Sato, Kyoko

AU - Sato, Takayuki

AU - Doi, Yoshinori

AU - Sugiura, Tetsuro

PY - 2011/5/1

Y1 - 2011/5/1

N2 - Although aspirin has become an established medicine for cardiac and cerebrovascular diseases, the optimal dose remains unknown. We evaluated the optimal dose of aspirin on platelet activity and endothelial function by administering 11 healthy male volunteers (32 ± 6 years of age) doses of aspirin that were increased in a stepwise manner (0, 81, 162, 330 and 660 mg/day) every 3 days. Platelet activity was assessed as surface P-selectin expression (%) measured by flow cytometry and the platelet aggregation ratio. Endothelial function in the brachial artery was assessed by measuring flow-mediated dilation (FMD) before and after reactive hyperemia. Platelet aggregation and P-selectin expression were significantly and dose-dependently suppressed (81-660 mg), and the FMD ratio tended to increase from 0 to 162 mg, but decreased significantly at 660 mg. In conclusion, although aspirin suppressed platelet activity and even surface P-selectin expression, higher doses worsened endothelial-mediated arterial dilation.

AB - Although aspirin has become an established medicine for cardiac and cerebrovascular diseases, the optimal dose remains unknown. We evaluated the optimal dose of aspirin on platelet activity and endothelial function by administering 11 healthy male volunteers (32 ± 6 years of age) doses of aspirin that were increased in a stepwise manner (0, 81, 162, 330 and 660 mg/day) every 3 days. Platelet activity was assessed as surface P-selectin expression (%) measured by flow cytometry and the platelet aggregation ratio. Endothelial function in the brachial artery was assessed by measuring flow-mediated dilation (FMD) before and after reactive hyperemia. Platelet aggregation and P-selectin expression were significantly and dose-dependently suppressed (81-660 mg), and the FMD ratio tended to increase from 0 to 162 mg, but decreased significantly at 660 mg. In conclusion, although aspirin suppressed platelet activity and even surface P-selectin expression, higher doses worsened endothelial-mediated arterial dilation.

UR - http://www.scopus.com/inward/record.url?scp=79959760348&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959760348&partnerID=8YFLogxK

U2 - 10.1007/s00380-010-0054-8

DO - 10.1007/s00380-010-0054-8

M3 - Article

C2 - 21063876

AN - SCOPUS:79959760348

VL - 26

SP - 267

EP - 273

JO - Heart and Vessels

JF - Heart and Vessels

SN - 0910-8327

IS - 3

ER -